nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—SLC22A1—Estropipate—osteoporosis	0.142	0.213	CbGbCtD
Midazolam—SLC22A1—Estradiol—osteoporosis	0.0588	0.0883	CbGbCtD
Midazolam—CYP2B6—Raloxifene—osteoporosis	0.0564	0.0847	CbGbCtD
Midazolam—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0545	0.0818	CbGbCtD
Midazolam—CYP2B6—Cholecalciferol—osteoporosis	0.0436	0.0654	CbGbCtD
Midazolam—CYP3A7—Estradiol—osteoporosis	0.0369	0.0554	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0369	0.0554	CbGbCtD
Midazolam—ABCB1—Ethinyl Estradiol—osteoporosis	0.0279	0.042	CbGbCtD
Midazolam—CYP3A5—Estradiol—osteoporosis	0.0277	0.0415	CbGbCtD
Midazolam—CYP3A4—Estropipate—osteoporosis	0.026	0.039	CbGbCtD
Midazolam—CYP3A4—Calcitriol—osteoporosis	0.026	0.039	CbGbCtD
Midazolam—CYP3A4—Ergocalciferol—osteoporosis	0.0208	0.0312	CbGbCtD
Midazolam—ABCB1—Conjugated Estrogens—osteoporosis	0.0205	0.0308	CbGbCtD
Midazolam—ABCB1—Estradiol—osteoporosis	0.018	0.027	CbGbCtD
Midazolam—CYP3A4—Raloxifene—osteoporosis	0.0173	0.026	CbGbCtD
Midazolam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0167	0.0251	CbGbCtD
Midazolam—CYP3A4—Cholecalciferol—osteoporosis	0.0134	0.0201	CbGbCtD
Midazolam—CYP3A4—Conjugated Estrogens—osteoporosis	0.0123	0.0185	CbGbCtD
Midazolam—CYP3A4—Estradiol—osteoporosis	0.0108	0.0162	CbGbCtD
Midazolam—Anxiety—Ethinyl Estradiol—osteoporosis	0.000405	0.00143	CcSEcCtD
Midazolam—Pain—Alendronate—osteoporosis	0.000404	0.00143	CcSEcCtD
Midazolam—Constipation—Alendronate—osteoporosis	0.000404	0.00143	CcSEcCtD
Midazolam—Erythema—Zoledronate—osteoporosis	0.000404	0.00142	CcSEcCtD
Midazolam—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000403	0.00142	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000403	0.00142	CcSEcCtD
Midazolam—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000402	0.00142	CcSEcCtD
Midazolam—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000402	0.00142	CcSEcCtD
Midazolam—Somnolence—Calcitriol—osteoporosis	0.000401	0.00141	CcSEcCtD
Midazolam—Pain—Raloxifene—osteoporosis	0.000398	0.0014	CcSEcCtD
Midazolam—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000398	0.0014	CcSEcCtD
Midazolam—Depression—Estradiol—osteoporosis	0.000397	0.0014	CcSEcCtD
Midazolam—Fatigue—Ibandronate—osteoporosis	0.000397	0.0014	CcSEcCtD
Midazolam—Syncope—Pamidronate—osteoporosis	0.000396	0.0014	CcSEcCtD
Midazolam—Anxiety—Risedronate—osteoporosis	0.000394	0.00139	CcSEcCtD
Midazolam—Constipation—Ibandronate—osteoporosis	0.000394	0.00139	CcSEcCtD
Midazolam—Pain—Ibandronate—osteoporosis	0.000394	0.00139	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000393	0.00139	CcSEcCtD
Midazolam—Pruritus—Etidronic acid—osteoporosis	0.000393	0.00138	CcSEcCtD
Midazolam—Mental disorder—Conjugated Estrogens—osteoporosis	0.000391	0.00138	CcSEcCtD
Midazolam—Neuropathy peripheral—Estradiol—osteoporosis	0.00039	0.00138	CcSEcCtD
Midazolam—Feeling abnormal—Alendronate—osteoporosis	0.00039	0.00137	CcSEcCtD
Midazolam—Erythema—Conjugated Estrogens—osteoporosis	0.000389	0.00137	CcSEcCtD
Midazolam—Dry mouth—Risedronate—osteoporosis	0.000387	0.00136	CcSEcCtD
Midazolam—Cough—Pamidronate—osteoporosis	0.000386	0.00136	CcSEcCtD
Midazolam—Constipation—Calcitriol—osteoporosis	0.000385	0.00136	CcSEcCtD
Midazolam—Pain—Calcitriol—osteoporosis	0.000385	0.00136	CcSEcCtD
Midazolam—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000382	0.00135	CcSEcCtD
Midazolam—Tension—Conjugated Estrogens—osteoporosis	0.000381	0.00134	CcSEcCtD
Midazolam—Urticaria—Estropipate—osteoporosis	0.000381	0.00134	CcSEcCtD
Midazolam—Vision blurred—Zoledronate—osteoporosis	0.00038	0.00134	CcSEcCtD
Midazolam—Feeling abnormal—Ibandronate—osteoporosis	0.000379	0.00134	CcSEcCtD
Midazolam—Tremor—Zoledronate—osteoporosis	0.000378	0.00133	CcSEcCtD
Midazolam—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000378	0.00133	CcSEcCtD
Midazolam—Nervousness—Conjugated Estrogens—osteoporosis	0.000378	0.00133	CcSEcCtD
Midazolam—Urticaria—Alendronate—osteoporosis	0.000376	0.00132	CcSEcCtD
Midazolam—Anxiety—Pamidronate—osteoporosis	0.000375	0.00132	CcSEcCtD
Midazolam—Shock—Risedronate—osteoporosis	0.000373	0.00132	CcSEcCtD
Midazolam—Nervous system disorder—Risedronate—osteoporosis	0.000372	0.00131	CcSEcCtD
Midazolam—Agitation—Zoledronate—osteoporosis	0.000371	0.00131	CcSEcCtD
Midazolam—Skin disorder—Risedronate—osteoporosis	0.000369	0.0013	CcSEcCtD
Midazolam—Vision blurred—Conjugated Estrogens—osteoporosis	0.000366	0.00129	CcSEcCtD
Midazolam—Urticaria—Ibandronate—osteoporosis	0.000366	0.00129	CcSEcCtD
Midazolam—Confusional state—Pamidronate—osteoporosis	0.000364	0.00128	CcSEcCtD
Midazolam—Vertigo—Zoledronate—osteoporosis	0.000363	0.00128	CcSEcCtD
Midazolam—Syncope—Zoledronate—osteoporosis	0.000362	0.00128	CcSEcCtD
Midazolam—Anaphylactic shock—Pamidronate—osteoporosis	0.000361	0.00127	CcSEcCtD
Midazolam—Urticaria—Calcitriol—osteoporosis	0.000358	0.00126	CcSEcCtD
Midazolam—Shock—Pamidronate—osteoporosis	0.000355	0.00125	CcSEcCtD
Midazolam—Hypersensitivity—Estropipate—osteoporosis	0.000354	0.00125	CcSEcCtD
Midazolam—Nervous system disorder—Pamidronate—osteoporosis	0.000354	0.00125	CcSEcCtD
Midazolam—Vomiting—Etidronic acid—osteoporosis	0.000353	0.00124	CcSEcCtD
Midazolam—Cough—Zoledronate—osteoporosis	0.000352	0.00124	CcSEcCtD
Midazolam—Tachycardia—Pamidronate—osteoporosis	0.000352	0.00124	CcSEcCtD
Midazolam—Connective tissue disorder—Estradiol—osteoporosis	0.000351	0.00124	CcSEcCtD
Midazolam—Rash—Etidronic acid—osteoporosis	0.00035	0.00123	CcSEcCtD
Midazolam—Dermatitis—Etidronic acid—osteoporosis	0.00035	0.00123	CcSEcCtD
Midazolam—Vertigo—Conjugated Estrogens—osteoporosis	0.000349	0.00123	CcSEcCtD
Midazolam—Syncope—Conjugated Estrogens—osteoporosis	0.000349	0.00123	CcSEcCtD
Midazolam—Hypersensitivity—Alendronate—osteoporosis	0.000348	0.00123	CcSEcCtD
Midazolam—Headache—Etidronic acid—osteoporosis	0.000348	0.00123	CcSEcCtD
Midazolam—Asthenia—Estropipate—osteoporosis	0.000344	0.00121	CcSEcCtD
Midazolam—Visual impairment—Estradiol—osteoporosis	0.000344	0.00121	CcSEcCtD
Midazolam—Anxiety—Zoledronate—osteoporosis	0.000343	0.00121	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000341	0.0012	CcSEcCtD
Midazolam—Paraesthesia—Risedronate—osteoporosis	0.000341	0.0012	CcSEcCtD
Midazolam—Pruritus—Estropipate—osteoporosis	0.00034	0.0012	CcSEcCtD
Midazolam—Asthenia—Alendronate—osteoporosis	0.000339	0.0012	CcSEcCtD
Midazolam—Hypersensitivity—Ibandronate—osteoporosis	0.000339	0.0012	CcSEcCtD
Midazolam—Cough—Conjugated Estrogens—osteoporosis	0.000339	0.0012	CcSEcCtD
Midazolam—Dyspnoea—Risedronate—osteoporosis	0.000338	0.00119	CcSEcCtD
Midazolam—Hypotension—Pamidronate—osteoporosis	0.000337	0.00119	CcSEcCtD
Midazolam—Dry mouth—Zoledronate—osteoporosis	0.000336	0.00118	CcSEcCtD
Midazolam—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000336	0.00118	CcSEcCtD
Midazolam—Fatigue—Ethinyl Estradiol—osteoporosis	0.000336	0.00118	CcSEcCtD
Midazolam—Pruritus—Alendronate—osteoporosis	0.000335	0.00118	CcSEcCtD
Midazolam—Dyspepsia—Risedronate—osteoporosis	0.000334	0.00118	CcSEcCtD
Midazolam—Eye disorder—Estradiol—osteoporosis	0.000334	0.00118	CcSEcCtD
Midazolam—Constipation—Ethinyl Estradiol—osteoporosis	0.000333	0.00117	CcSEcCtD
Midazolam—Confusional state—Zoledronate—osteoporosis	0.000332	0.00117	CcSEcCtD
Midazolam—Hypersensitivity—Calcitriol—osteoporosis	0.000332	0.00117	CcSEcCtD
Midazolam—Cardiac disorder—Estradiol—osteoporosis	0.000332	0.00117	CcSEcCtD
Midazolam—Asthenia—Ibandronate—osteoporosis	0.00033	0.00116	CcSEcCtD
Midazolam—Anxiety—Conjugated Estrogens—osteoporosis	0.00033	0.00116	CcSEcCtD
Midazolam—Nausea—Etidronic acid—osteoporosis	0.00033	0.00116	CcSEcCtD
Midazolam—Anaphylactic shock—Zoledronate—osteoporosis	0.000329	0.00116	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000329	0.00116	CcSEcCtD
Midazolam—Gastrointestinal disorder—Risedronate—osteoporosis	0.000328	0.00115	CcSEcCtD
Midazolam—Fatigue—Risedronate—osteoporosis	0.000327	0.00115	CcSEcCtD
Midazolam—Pruritus—Ibandronate—osteoporosis	0.000326	0.00115	CcSEcCtD
Midazolam—Constipation—Risedronate—osteoporosis	0.000324	0.00114	CcSEcCtD
Midazolam—Pain—Risedronate—osteoporosis	0.000324	0.00114	CcSEcCtD
Midazolam—Shock—Zoledronate—osteoporosis	0.000324	0.00114	CcSEcCtD
Midazolam—Paraesthesia—Pamidronate—osteoporosis	0.000324	0.00114	CcSEcCtD
Midazolam—Asthenia—Calcitriol—osteoporosis	0.000323	0.00114	CcSEcCtD
Midazolam—Nervous system disorder—Zoledronate—osteoporosis	0.000323	0.00114	CcSEcCtD
Midazolam—Immune system disorder—Estradiol—osteoporosis	0.000323	0.00114	CcSEcCtD
Midazolam—Mediastinal disorder—Estradiol—osteoporosis	0.000322	0.00114	CcSEcCtD
Midazolam—Dyspnoea—Pamidronate—osteoporosis	0.000322	0.00113	CcSEcCtD
Midazolam—Tachycardia—Zoledronate—osteoporosis	0.000322	0.00113	CcSEcCtD
Midazolam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000321	0.00113	CcSEcCtD
Midazolam—Chills—Estradiol—osteoporosis	0.000321	0.00113	CcSEcCtD
Midazolam—Somnolence—Pamidronate—osteoporosis	0.000321	0.00113	CcSEcCtD
Midazolam—Skin disorder—Zoledronate—osteoporosis	0.00032	0.00113	CcSEcCtD
Midazolam—Pruritus—Calcitriol—osteoporosis	0.000319	0.00112	CcSEcCtD
Midazolam—Dyspepsia—Pamidronate—osteoporosis	0.000318	0.00112	CcSEcCtD
Midazolam—Dizziness—Estropipate—osteoporosis	0.000318	0.00112	CcSEcCtD
Midazolam—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000317	0.00112	CcSEcCtD
Midazolam—Mental disorder—Estradiol—osteoporosis	0.000313	0.0011	CcSEcCtD
Midazolam—Dizziness—Alendronate—osteoporosis	0.000313	0.0011	CcSEcCtD
Midazolam—Shock—Conjugated Estrogens—osteoporosis	0.000312	0.0011	CcSEcCtD
Midazolam—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000311	0.0011	CcSEcCtD
Midazolam—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000311	0.0011	CcSEcCtD
Midazolam—Erythema—Estradiol—osteoporosis	0.000311	0.0011	CcSEcCtD
Midazolam—Fatigue—Pamidronate—osteoporosis	0.000311	0.0011	CcSEcCtD
Midazolam—Tachycardia—Conjugated Estrogens—osteoporosis	0.00031	0.00109	CcSEcCtD
Midazolam—Urticaria—Ethinyl Estradiol—osteoporosis	0.000309	0.00109	CcSEcCtD
Midazolam—Pain—Pamidronate—osteoporosis	0.000308	0.00109	CcSEcCtD
Midazolam—Constipation—Pamidronate—osteoporosis	0.000308	0.00109	CcSEcCtD
Midazolam—Skin disorder—Conjugated Estrogens—osteoporosis	0.000308	0.00109	CcSEcCtD
Midazolam—Hypotension—Zoledronate—osteoporosis	0.000308	0.00109	CcSEcCtD
Midazolam—Dizziness—Raloxifene—osteoporosis	0.000308	0.00108	CcSEcCtD
Midazolam—Tension—Estradiol—osteoporosis	0.000305	0.00108	CcSEcCtD
Midazolam—Vomiting—Estropipate—osteoporosis	0.000305	0.00108	CcSEcCtD
Midazolam—Dizziness—Ibandronate—osteoporosis	0.000304	0.00107	CcSEcCtD
Midazolam—Rash—Estropipate—osteoporosis	0.000303	0.00107	CcSEcCtD
Midazolam—Dermatitis—Estropipate—osteoporosis	0.000302	0.00107	CcSEcCtD
Midazolam—Nervousness—Estradiol—osteoporosis	0.000302	0.00106	CcSEcCtD
Midazolam—Urticaria—Risedronate—osteoporosis	0.000301	0.00106	CcSEcCtD
Midazolam—Headache—Estropipate—osteoporosis	0.000301	0.00106	CcSEcCtD
Midazolam—Vomiting—Alendronate—osteoporosis	0.000301	0.00106	CcSEcCtD
Midazolam—Rash—Alendronate—osteoporosis	0.000298	0.00105	CcSEcCtD
Midazolam—Dermatitis—Alendronate—osteoporosis	0.000298	0.00105	CcSEcCtD
Midazolam—Feeling abnormal—Pamidronate—osteoporosis	0.000297	0.00105	CcSEcCtD
Midazolam—Hypotension—Conjugated Estrogens—osteoporosis	0.000296	0.00104	CcSEcCtD
Midazolam—Headache—Alendronate—osteoporosis	0.000296	0.00104	CcSEcCtD
Midazolam—Paraesthesia—Zoledronate—osteoporosis	0.000296	0.00104	CcSEcCtD
Midazolam—Vomiting—Raloxifene—osteoporosis	0.000296	0.00104	CcSEcCtD
Midazolam—Dyspnoea—Zoledronate—osteoporosis	0.000294	0.00104	CcSEcCtD
Midazolam—Rash—Raloxifene—osteoporosis	0.000293	0.00103	CcSEcCtD
Midazolam—Dermatitis—Raloxifene—osteoporosis	0.000293	0.00103	CcSEcCtD
Midazolam—Somnolence—Zoledronate—osteoporosis	0.000293	0.00103	CcSEcCtD
Midazolam—Vomiting—Ibandronate—osteoporosis	0.000293	0.00103	CcSEcCtD
Midazolam—Tremor—Estradiol—osteoporosis	0.000291	0.00103	CcSEcCtD
Midazolam—Headache—Raloxifene—osteoporosis	0.000291	0.00103	CcSEcCtD
Midazolam—Rash—Ibandronate—osteoporosis	0.00029	0.00102	CcSEcCtD
Midazolam—Dermatitis—Ibandronate—osteoporosis	0.00029	0.00102	CcSEcCtD
Midazolam—Dyspepsia—Zoledronate—osteoporosis	0.00029	0.00102	CcSEcCtD
Midazolam—Headache—Ibandronate—osteoporosis	0.000288	0.00102	CcSEcCtD
Midazolam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000287	0.00101	CcSEcCtD
Midazolam—Vomiting—Calcitriol—osteoporosis	0.000287	0.00101	CcSEcCtD
Midazolam—Agitation—Estradiol—osteoporosis	0.000286	0.00101	CcSEcCtD
Midazolam—Nausea—Estropipate—osteoporosis	0.000285	0.00101	CcSEcCtD
Midazolam—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000285	0.001	CcSEcCtD
Midazolam—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000284	0.001	CcSEcCtD
Midazolam—Rash—Calcitriol—osteoporosis	0.000284	0.001	CcSEcCtD
Midazolam—Fatigue—Zoledronate—osteoporosis	0.000284	0.001	CcSEcCtD
Midazolam—Dermatitis—Calcitriol—osteoporosis	0.000284	0.001	CcSEcCtD
Midazolam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000283	0.000997	CcSEcCtD
Midazolam—Headache—Calcitriol—osteoporosis	0.000282	0.000995	CcSEcCtD
Midazolam—Somnolence—Conjugated Estrogens—osteoporosis	0.000282	0.000994	CcSEcCtD
Midazolam—Constipation—Zoledronate—osteoporosis	0.000282	0.000993	CcSEcCtD
Midazolam—Pain—Zoledronate—osteoporosis	0.000282	0.000993	CcSEcCtD
Midazolam—Nausea—Alendronate—osteoporosis	0.000281	0.00099	CcSEcCtD
Midazolam—Hypersensitivity—Risedronate—osteoporosis	0.00028	0.000985	CcSEcCtD
Midazolam—Vertigo—Estradiol—osteoporosis	0.00028	0.000985	CcSEcCtD
Midazolam—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000279	0.000984	CcSEcCtD
Midazolam—Asthenia—Ethinyl Estradiol—osteoporosis	0.000279	0.000984	CcSEcCtD
Midazolam—Syncope—Estradiol—osteoporosis	0.000279	0.000983	CcSEcCtD
Midazolam—Nausea—Raloxifene—osteoporosis	0.000276	0.000974	CcSEcCtD
Midazolam—Pruritus—Ethinyl Estradiol—osteoporosis	0.000275	0.00097	CcSEcCtD
Midazolam—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000274	0.000965	CcSEcCtD
Midazolam—Fatigue—Conjugated Estrogens—osteoporosis	0.000274	0.000964	CcSEcCtD
Midazolam—Nausea—Ibandronate—osteoporosis	0.000273	0.000964	CcSEcCtD
Midazolam—Asthenia—Risedronate—osteoporosis	0.000272	0.00096	CcSEcCtD
Midazolam—Feeling abnormal—Zoledronate—osteoporosis	0.000272	0.000957	CcSEcCtD
Midazolam—Cough—Estradiol—osteoporosis	0.000271	0.000957	CcSEcCtD
Midazolam—Constipation—Conjugated Estrogens—osteoporosis	0.000271	0.000956	CcSEcCtD
Midazolam—Pain—Conjugated Estrogens—osteoporosis	0.000271	0.000956	CcSEcCtD
Midazolam—Pruritus—Risedronate—osteoporosis	0.000268	0.000946	CcSEcCtD
Midazolam—Nausea—Calcitriol—osteoporosis	0.000268	0.000944	CcSEcCtD
Midazolam—Hypersensitivity—Pamidronate—osteoporosis	0.000266	0.000937	CcSEcCtD
Midazolam—Anxiety—Estradiol—osteoporosis	0.000264	0.00093	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000263	0.000927	CcSEcCtD
Midazolam—Urticaria—Zoledronate—osteoporosis	0.000262	0.000923	CcSEcCtD
Midazolam—Dry mouth—Estradiol—osteoporosis	0.000259	0.000913	CcSEcCtD
Midazolam—Asthenia—Pamidronate—osteoporosis	0.000259	0.000912	CcSEcCtD
Midazolam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000257	0.000907	CcSEcCtD
Midazolam—Confusional state—Estradiol—osteoporosis	0.000256	0.000902	CcSEcCtD
Midazolam—Pruritus—Pamidronate—osteoporosis	0.000255	0.000899	CcSEcCtD
Midazolam—Anaphylactic shock—Estradiol—osteoporosis	0.000254	0.000895	CcSEcCtD
Midazolam—Urticaria—Conjugated Estrogens—osteoporosis	0.000252	0.000888	CcSEcCtD
Midazolam—Dizziness—Risedronate—osteoporosis	0.000251	0.000884	CcSEcCtD
Midazolam—Shock—Estradiol—osteoporosis	0.00025	0.00088	CcSEcCtD
Midazolam—Nervous system disorder—Estradiol—osteoporosis	0.000249	0.000878	CcSEcCtD
Midazolam—Tachycardia—Estradiol—osteoporosis	0.000248	0.000873	CcSEcCtD
Midazolam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000247	0.000872	CcSEcCtD
Midazolam—Skin disorder—Estradiol—osteoporosis	0.000247	0.000869	CcSEcCtD
Midazolam—Rash—Ethinyl Estradiol—osteoporosis	0.000245	0.000865	CcSEcCtD
Midazolam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000245	0.000864	CcSEcCtD
Midazolam—Headache—Ethinyl Estradiol—osteoporosis	0.000244	0.000859	CcSEcCtD
Midazolam—Hypersensitivity—Zoledronate—osteoporosis	0.000243	0.000856	CcSEcCtD
Midazolam—Vomiting—Risedronate—osteoporosis	0.000241	0.00085	CcSEcCtD
Midazolam—Rash—Risedronate—osteoporosis	0.000239	0.000843	CcSEcCtD
Midazolam—Dermatitis—Risedronate—osteoporosis	0.000239	0.000842	CcSEcCtD
Midazolam—Dizziness—Pamidronate—osteoporosis	0.000239	0.000841	CcSEcCtD
Midazolam—Headache—Risedronate—osteoporosis	0.000238	0.000838	CcSEcCtD
Midazolam—Asthenia—Zoledronate—osteoporosis	0.000236	0.000833	CcSEcCtD
Midazolam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000234	0.000824	CcSEcCtD
Midazolam—Pruritus—Zoledronate—osteoporosis	0.000233	0.000822	CcSEcCtD
Midazolam—Nausea—Ethinyl Estradiol—osteoporosis	0.000231	0.000815	CcSEcCtD
Midazolam—Vomiting—Pamidronate—osteoporosis	0.000229	0.000808	CcSEcCtD
Midazolam—Paraesthesia—Estradiol—osteoporosis	0.000228	0.000804	CcSEcCtD
Midazolam—Asthenia—Conjugated Estrogens—osteoporosis	0.000228	0.000802	CcSEcCtD
Midazolam—Rash—Pamidronate—osteoporosis	0.000227	0.000802	CcSEcCtD
Midazolam—Dermatitis—Pamidronate—osteoporosis	0.000227	0.000801	CcSEcCtD
Midazolam—Dyspnoea—Estradiol—osteoporosis	0.000226	0.000798	CcSEcCtD
Midazolam—Headache—Pamidronate—osteoporosis	0.000226	0.000796	CcSEcCtD
Midazolam—Somnolence—Estradiol—osteoporosis	0.000226	0.000796	CcSEcCtD
Midazolam—Nausea—Risedronate—osteoporosis	0.000225	0.000794	CcSEcCtD
Midazolam—Pruritus—Conjugated Estrogens—osteoporosis	0.000224	0.000791	CcSEcCtD
Midazolam—Dyspepsia—Estradiol—osteoporosis	0.000224	0.000788	CcSEcCtD
Midazolam—Gastrointestinal disorder—Estradiol—osteoporosis	0.000219	0.000773	CcSEcCtD
Midazolam—Fatigue—Estradiol—osteoporosis	0.000219	0.000772	CcSEcCtD
Midazolam—Dizziness—Zoledronate—osteoporosis	0.000218	0.000768	CcSEcCtD
Midazolam—Pain—Estradiol—osteoporosis	0.000217	0.000765	CcSEcCtD
Midazolam—Constipation—Estradiol—osteoporosis	0.000217	0.000765	CcSEcCtD
Midazolam—Nausea—Pamidronate—osteoporosis	0.000214	0.000755	CcSEcCtD
Midazolam—Dizziness—Conjugated Estrogens—osteoporosis	0.00021	0.000739	CcSEcCtD
Midazolam—Vomiting—Zoledronate—osteoporosis	0.000209	0.000738	CcSEcCtD
Midazolam—Feeling abnormal—Estradiol—osteoporosis	0.000209	0.000737	CcSEcCtD
Midazolam—Rash—Zoledronate—osteoporosis	0.000208	0.000732	CcSEcCtD
Midazolam—Dermatitis—Zoledronate—osteoporosis	0.000208	0.000732	CcSEcCtD
Midazolam—Headache—Zoledronate—osteoporosis	0.000206	0.000727	CcSEcCtD
Midazolam—Vomiting—Conjugated Estrogens—osteoporosis	0.000202	0.000711	CcSEcCtD
Midazolam—Urticaria—Estradiol—osteoporosis	0.000202	0.000711	CcSEcCtD
Midazolam—Rash—Conjugated Estrogens—osteoporosis	0.0002	0.000705	CcSEcCtD
Midazolam—Dermatitis—Conjugated Estrogens—osteoporosis	0.0002	0.000704	CcSEcCtD
Midazolam—Headache—Conjugated Estrogens—osteoporosis	0.000199	0.0007	CcSEcCtD
Midazolam—Nausea—Zoledronate—osteoporosis	0.000196	0.00069	CcSEcCtD
Midazolam—Nausea—Conjugated Estrogens—osteoporosis	0.000188	0.000664	CcSEcCtD
Midazolam—Hypersensitivity—Estradiol—osteoporosis	0.000187	0.000659	CcSEcCtD
Midazolam—Asthenia—Estradiol—osteoporosis	0.000182	0.000642	CcSEcCtD
Midazolam—Pruritus—Estradiol—osteoporosis	0.00018	0.000633	CcSEcCtD
Midazolam—Dizziness—Estradiol—osteoporosis	0.000168	0.000592	CcSEcCtD
Midazolam—Vomiting—Estradiol—osteoporosis	0.000161	0.000569	CcSEcCtD
Midazolam—Rash—Estradiol—osteoporosis	0.00016	0.000564	CcSEcCtD
Midazolam—Dermatitis—Estradiol—osteoporosis	0.00016	0.000564	CcSEcCtD
Midazolam—Headache—Estradiol—osteoporosis	0.000159	0.000561	CcSEcCtD
Midazolam—Nausea—Estradiol—osteoporosis	0.000151	0.000532	CcSEcCtD
Midazolam—GABRB2—Neuronal System—ADCY5—osteoporosis	6.46e-05	0.00129	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.33e-05	0.00126	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	6.33e-05	0.00126	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—ADCY5—osteoporosis	6.28e-05	0.00125	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	6.24e-05	0.00124	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	6.2e-05	0.00123	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	6.19e-05	0.00123	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—ADCY5—osteoporosis	6.16e-05	0.00123	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—IDH2—osteoporosis	6.13e-05	0.00122	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	6.11e-05	0.00122	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	6.1e-05	0.00121	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ENO1—osteoporosis	6.06e-05	0.00121	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—ADCY5—osteoporosis	6.06e-05	0.00121	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—ADCY5—osteoporosis	6.02e-05	0.0012	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PSMA2—osteoporosis	5.97e-05	0.00119	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PSMA5—osteoporosis	5.97e-05	0.00119	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—ADCY5—osteoporosis	5.91e-05	0.00118	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	5.9e-05	0.00117	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP27A1—osteoporosis	5.77e-05	0.00115	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.77e-05	0.00115	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ACP5—osteoporosis	5.61e-05	0.00112	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	5.48e-05	0.00109	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.41e-05	0.00108	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.4e-05	0.00108	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.25e-05	0.00105	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TPI1—osteoporosis	5.22e-05	0.00104	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—ADCY5—osteoporosis	5.16e-05	0.00103	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—POMC—osteoporosis	5.14e-05	0.00102	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.01e-05	0.000998	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.01e-05	0.000998	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—P4HB—osteoporosis	4.9e-05	0.000977	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PKM—osteoporosis	4.85e-05	0.000966	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—FDPS—osteoporosis	4.85e-05	0.000966	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP19A1—osteoporosis	4.84e-05	0.000964	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GAPDH—osteoporosis	4.81e-05	0.000959	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	4.73e-05	0.000941	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—RAP1A—osteoporosis	4.69e-05	0.000934	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPD2—osteoporosis	4.6e-05	0.000916	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PGLS—osteoporosis	4.6e-05	0.000916	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PKM—osteoporosis	4.51e-05	0.000899	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—FDPS—osteoporosis	4.51e-05	0.000899	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.49e-05	0.000894	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	4.43e-05	0.000882	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—ADCY5—osteoporosis	4.42e-05	0.00088	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPD2—osteoporosis	4.28e-05	0.000852	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PGLS—osteoporosis	4.28e-05	0.000852	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PNP—osteoporosis	4.21e-05	0.000838	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ATIC—osteoporosis	4.21e-05	0.000838	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.13e-05	0.000822	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.06e-05	0.000809	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.01e-05	0.000799	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ADCY5—osteoporosis	3.96e-05	0.000788	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GPX1—osteoporosis	3.94e-05	0.000785	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PNP—osteoporosis	3.91e-05	0.000779	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ATIC—osteoporosis	3.91e-05	0.000779	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL1B—osteoporosis	3.88e-05	0.000773	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.85e-05	0.000766	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—POMC—osteoporosis	3.8e-05	0.000757	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.8e-05	0.000756	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ENO1—osteoporosis	3.79e-05	0.000755	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PSMA2—osteoporosis	3.73e-05	0.000744	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PSMA5—osteoporosis	3.73e-05	0.000744	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—POMC—osteoporosis	3.73e-05	0.000742	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—POMC—osteoporosis	3.72e-05	0.00074	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.71e-05	0.000739	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—MTHFR—osteoporosis	3.64e-05	0.000725	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—FDPS—osteoporosis	3.59e-05	0.000714	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PKM—osteoporosis	3.59e-05	0.000714	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—OXCT1—osteoporosis	3.58e-05	0.000712	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CA2—osteoporosis	3.58e-05	0.000712	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—FDPS—osteoporosis	3.51e-05	0.0007	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PKM—osteoporosis	3.51e-05	0.0007	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—FDPS—osteoporosis	3.51e-05	0.000698	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PKM—osteoporosis	3.51e-05	0.000698	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MGLL—osteoporosis	3.49e-05	0.000694	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.47e-05	0.000692	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PGLS—osteoporosis	3.4e-05	0.000677	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPD2—osteoporosis	3.4e-05	0.000677	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.37e-05	0.000672	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPD2—osteoporosis	3.33e-05	0.000663	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PGLS—osteoporosis	3.33e-05	0.000663	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CA2—osteoporosis	3.33e-05	0.000663	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—OXCT1—osteoporosis	3.33e-05	0.000663	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPD2—osteoporosis	3.32e-05	0.000662	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PGLS—osteoporosis	3.32e-05	0.000662	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.31e-05	0.00066	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	3.26e-05	0.000648	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.26e-05	0.000648	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.25e-05	0.000648	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MGLL—osteoporosis	3.24e-05	0.000646	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.23e-05	0.000644	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.18e-05	0.000633	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PNP—osteoporosis	3.11e-05	0.000619	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ATIC—osteoporosis	3.11e-05	0.000619	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ATIC—osteoporosis	3.05e-05	0.000607	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PNP—osteoporosis	3.05e-05	0.000607	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ATIC—osteoporosis	3.04e-05	0.000605	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PNP—osteoporosis	3.04e-05	0.000605	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP19A1—osteoporosis	3.03e-05	0.000603	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.01e-05	0.0006	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—IDH2—osteoporosis	2.96e-05	0.00059	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—POMC—osteoporosis	2.91e-05	0.00058	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.88e-05	0.000573	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.87e-05	0.000571	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.84e-05	0.000565	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—osteoporosis	2.82e-05	0.000561	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP27A1—osteoporosis	2.79e-05	0.000555	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.78e-05	0.000553	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—IDH2—osteoporosis	2.76e-05	0.000549	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ACP5—osteoporosis	2.71e-05	0.00054	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FDPS—osteoporosis	2.65e-05	0.000527	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PKM—osteoporosis	2.65e-05	0.000527	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CA2—osteoporosis	2.64e-05	0.000527	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—OXCT1—osteoporosis	2.64e-05	0.000527	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	2.63e-05	0.000523	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP27A1—osteoporosis	2.59e-05	0.000516	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—OXCT1—osteoporosis	2.59e-05	0.000516	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CA2—osteoporosis	2.59e-05	0.000516	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CA2—osteoporosis	2.59e-05	0.000515	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—OXCT1—osteoporosis	2.59e-05	0.000515	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MGLL—osteoporosis	2.58e-05	0.000513	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MGLL—osteoporosis	2.52e-05	0.000503	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ACP5—osteoporosis	2.52e-05	0.000502	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TPI1—osteoporosis	2.52e-05	0.000502	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MGLL—osteoporosis	2.52e-05	0.000502	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPD2—osteoporosis	2.51e-05	0.000499	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PGLS—osteoporosis	2.51e-05	0.000499	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.48e-05	0.000494	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ADCY5—osteoporosis	2.48e-05	0.000493	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GPX1—osteoporosis	2.47e-05	0.000491	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.38e-05	0.000473	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—P4HB—osteoporosis	2.37e-05	0.000472	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TPI1—osteoporosis	2.34e-05	0.000467	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GAPDH—osteoporosis	2.33e-05	0.000463	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ATIC—osteoporosis	2.29e-05	0.000457	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PNP—osteoporosis	2.29e-05	0.000457	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—MTHFR—osteoporosis	2.28e-05	0.000453	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—RAP1A—osteoporosis	2.26e-05	0.000451	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—P4HB—osteoporosis	2.2e-05	0.000439	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—IDH2—osteoporosis	2.19e-05	0.000436	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GAPDH—osteoporosis	2.16e-05	0.000431	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—IDH2—osteoporosis	2.15e-05	0.000427	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—IDH2—osteoporosis	2.14e-05	0.000427	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—RAP1A—osteoporosis	2.11e-05	0.00042	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.06e-05	0.00041	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP27A1—osteoporosis	2.02e-05	0.000402	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.01e-05	0.000401	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ACP5—osteoporosis	2e-05	0.000399	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ACP5—osteoporosis	1.96e-05	0.000391	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ACP5—osteoporosis	1.96e-05	0.00039	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—OXCT1—osteoporosis	1.95e-05	0.000388	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA2—osteoporosis	1.95e-05	0.000388	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MGLL—osteoporosis	1.9e-05	0.000379	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TPI1—osteoporosis	1.86e-05	0.000371	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ENO1—osteoporosis	1.83e-05	0.000365	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TPI1—osteoporosis	1.83e-05	0.000363	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TPI1—osteoporosis	1.82e-05	0.000363	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—POMC—osteoporosis	1.82e-05	0.000363	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSMA2—osteoporosis	1.8e-05	0.000359	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSMA5—osteoporosis	1.8e-05	0.000359	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—P4HB—osteoporosis	1.75e-05	0.000349	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—POMC—osteoporosis	1.73e-05	0.000344	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GAPDH—osteoporosis	1.72e-05	0.000342	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—P4HB—osteoporosis	1.72e-05	0.000342	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—P4HB—osteoporosis	1.71e-05	0.000341	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ENO1—osteoporosis	1.7e-05	0.000339	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000335	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000335	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSMA2—osteoporosis	1.68e-05	0.000334	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSMA5—osteoporosis	1.68e-05	0.000334	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—RAP1A—osteoporosis	1.67e-05	0.000334	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—RAP1A—osteoporosis	1.64e-05	0.000327	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—RAP1A—osteoporosis	1.64e-05	0.000326	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PKM—osteoporosis	1.63e-05	0.000325	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FDPS—osteoporosis	1.63e-05	0.000325	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—IDH2—osteoporosis	1.62e-05	0.000322	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PGLS—osteoporosis	1.55e-05	0.000308	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPD2—osteoporosis	1.55e-05	0.000308	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP27A1—osteoporosis	1.52e-05	0.000303	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.49e-05	0.000297	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.49e-05	0.000296	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ACP5—osteoporosis	1.48e-05	0.000294	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.46e-05	0.000291	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PNP—osteoporosis	1.41e-05	0.000281	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ATIC—osteoporosis	1.41e-05	0.000281	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.39e-05	0.000277	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.39e-05	0.000277	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TPI1—osteoporosis	1.37e-05	0.000274	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP19A1—osteoporosis	1.36e-05	0.000271	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO1—osteoporosis	1.35e-05	0.00027	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSMA2—osteoporosis	1.33e-05	0.000266	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSMA5—osteoporosis	1.33e-05	0.000266	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO1—osteoporosis	1.33e-05	0.000264	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO1—osteoporosis	1.32e-05	0.000264	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSMA2—osteoporosis	1.31e-05	0.00026	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSMA5—osteoporosis	1.31e-05	0.00026	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSMA5—osteoporosis	1.3e-05	0.00026	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSMA2—osteoporosis	1.3e-05	0.00026	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—P4HB—osteoporosis	1.29e-05	0.000257	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000253	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000246	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—OXCT1—osteoporosis	1.2e-05	0.000239	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA2—osteoporosis	1.2e-05	0.000239	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ADCY5—osteoporosis	1.2e-05	0.000238	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPX1—osteoporosis	1.19e-05	0.000237	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MGLL—osteoporosis	1.17e-05	0.000233	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ADCY5—osteoporosis	1.11e-05	0.000222	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPX1—osteoporosis	1.11e-05	0.000221	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—osteoporosis	1.1e-05	0.000219	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000216	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000211	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000211	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—osteoporosis	1.02e-05	0.000204	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO1—osteoporosis	9.99e-06	0.000199	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH2—osteoporosis	9.96e-06	0.000198	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSMA2—osteoporosis	9.84e-06	0.000196	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSMA5—osteoporosis	9.84e-06	0.000196	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.36e-06	0.000186	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ACP5—osteoporosis	9.11e-06	0.000181	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADCY5—osteoporosis	8.84e-06	0.000176	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPX1—osteoporosis	8.81e-06	0.000176	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—osteoporosis	8.8e-06	0.000175	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADCY5—osteoporosis	8.66e-06	0.000172	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADCY5—osteoporosis	8.64e-06	0.000172	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPX1—osteoporosis	8.63e-06	0.000172	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPX1—osteoporosis	8.61e-06	0.000172	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TPI1—osteoporosis	8.47e-06	0.000169	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—osteoporosis	8.19e-06	0.000163	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—osteoporosis	8.13e-06	0.000162	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP19A1—osteoporosis	7.98e-06	0.000159	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—osteoporosis	7.97e-06	0.000159	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—P4HB—osteoporosis	7.96e-06	0.000159	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—osteoporosis	7.95e-06	0.000158	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GAPDH—osteoporosis	7.81e-06	0.000156	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RAP1A—osteoporosis	7.61e-06	0.000152	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADCY5—osteoporosis	6.52e-06	0.00013	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—osteoporosis	6.51e-06	0.00013	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPX1—osteoporosis	6.5e-06	0.000129	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—osteoporosis	6.37e-06	0.000127	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—osteoporosis	6.36e-06	0.000127	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO1—osteoporosis	6.15e-06	0.000123	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSMA2—osteoporosis	6.06e-06	0.000121	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSMA5—osteoporosis	6.06e-06	0.000121	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—osteoporosis	6e-06	0.000119	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.92e-06	9.79e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—osteoporosis	4.8e-06	9.55e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADCY5—osteoporosis	4.02e-06	8e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX1—osteoporosis	4.01e-06	7.98e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—osteoporosis	3.7e-06	7.36e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—osteoporosis	2.96e-06	5.89e-05	CbGpPWpGaD
